| Gene symbol | S | Synonyms | E2 | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_004718.3 (21492..25259) | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | spike glycoprotein | ||||
| GTO ID | GTC2657 |
| Trial ID | NCT04843774 |
| Disease | Multiple Sclerosis |
| Altered gene | S |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | SARS-COV-2 mRNA Vaccine |
| Recruitment status | Completed |
| Title | Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA) |
| Year | 2021 |
| Country | United States |
| Company sponsor | NYU Langone Health |
| Other ID(s) | 21-00206 |
| Cohort 1 | |||||||
|
|||||||